Month: February 2022

SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) —  Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced two upcoming presentations on the OTO-413 hearing loss program at the 49th Annual Scientific and Technology Meeting of the American Auditory Society (AAS) to be held February 24-26, 2022 in Scottsdale, Arizona. These include a podium presentation of previously disclosed results from the OTO-413 Phase 1/2 clinical trial and a general review of the OTO-413 program as an invited presentation in a special session on hearing therapeutics. Details of these presentations are as follows: Podium Presentation Title: Neurotrophin OTO-413 for hearing loss: Phase 1/2 clinical studyDate and Time: February 24, 2022 from 4:00-4:20 p.m. MSTPresenter: David...

BRIGHTON, Mich, Feb. 16, 2022 (GLOBE NEWSWIRE) — CGE Energy, Inc.’s (OTC: CGEI) subsidiary, Aradatum, a cleantech telecommunications technology company has assembled a best-in-class engineering and manufacturing team as the company prepares for their initial pilot installations of their next generation wireless tower infrastructure in early 2023. The Company is pleased to announce that it has expanded its strategic development partners by recently appointing Michigan technology and design firm Twisthink to lead Aradatum’s tower control system development. Twisthink is a digital consultancy that specializes in digital strategy and solutions. Custom IoT and control system solutions is one of their core competencies. Powered by Human-Centered Design and agile principles, Twisthink helps their clients discern what deserves to be built,...

Company reports positive clinical data assessing cardiovascular risk for patent-pending microdose compound DENVER, Feb. 16, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced the inclusion of a novel molecule with potentially heart-safe microdose enabling properties in their family of psilocin analogs. The Company has named this group of patent pending molecules MYCO-005. In December of 2021, Mydecine announced a patent application covering multiple families of psilocin analogs, MYCO-005. This family of second-generation molecules directly addresses delivery and stability concerns with the first-generation compounds. The Company reported that...

SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (the “Company” or “Salona”) (TSXV: SGMD), is pleased to announce that it has closed its previously announced bought deal private placement of units of the Company (the “Units”). A total of 7,749,000 Units were sold at a price of $0.55 per Unit for aggregate gross proceeds of approximately $4.26 million (the “Offering”), which included the partial exercise of the Underwriters’ (as defined below) option. The Offering was underwritten by a syndicate of underwriters led by Beacon Securities Limited and included Canaccord Genuity Corp. and Leede Jones Gable Inc. (collectively, the “Underwriters”). Each Unit consists of one common share of the Company (each, a “Common Share”) and one Common Share purchase warrant (each, a “Warrant”), with each Warrant...

Minim, Inc. Minim and Link Net Enter PartnershipLatest partnership marks continuation of Minim’s collaboration to increase access to intelligent Wi-Fi systems MANCHESTER, N.H., Feb. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Minim, Inc., (NASDAQ: MINM), the creator of intelligent Wi-Fi software and Motorola home networking products under an exclusive global brand license, today announces their partnership with PT Link Net Tbk (“Link Net” or the Company; stock code: “LINK”) one of the leading cable TV and fixed broadband internet providers in Indonesia with the brand “First Media”, as part of their ongoing activity as a participant in the TIP OpenWiFi initiative. This new relationship will bring Minim’s TIP OpenWiFi-driven routers and mesh systems and its mobile app deployed to Link Net subscribers throughout the country.   Featuring...

SOUTH SAN FRANCISCO, Calif. and OAKLAND, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) and the American Heart Association (AHA) Bay Area today announced a three-year collaboration to accelerate education and awareness of heart disease. Within the collaboration, Cytokinetics will provide funding and support for several initiatives led by AHA Bay Area. In 2022, Cytokinetics will sponsor the Research Roundtable, a life-sciences industry fundraising event. Cytokinetics will also support several Bay Area Heart Walks by establishing an enhanced VIP area for patients and caregivers, which will provide additional space for friends, families, coworkers and neighbors to demonstrate their commitment to their health and to honor loved ones with heart disease or stroke. Additionally, Cytokinetics will elevate...

Costerfield gold reserves increase by 24%; Björkdal maintains long mine life TORONTO, Feb. 16, 2022 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce updated Mineral Resources and Reserves estimates for its Costerfield gold-antimony mine in Victoria, Australia and its Björkdal gold mine in Skellefteå, Sweden as at December 31, 2021. All dollar amounts in this press release are in U.S. dollars unless otherwise noted. Highlights: CosterfieldProven and Probable Mineral Reserves for contained gold increased by 24%, net of depletion for 2021 production; and Extended mine life by two years to 2027, net of depletion for 2021 production.BjörkdalMaintains long mine life until 2030; Improved geological understanding allowing for upgrade...